GSK-200147

Study Sponsor: GSK

Study Title

Safety and immunogenicity study of 2 formulations of GSK Biologicals’ varicella vaccines given as a 2-dose course in the second year of life.

Medicine or Vaccine (generic name)

Varicella Vaccine

Sponsor Identification Number

200147

Trial Registry Identification Number(#'s)

NCT02570126 2013-003535-30

Medical Condition

Varicella

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

March 2019